Corbenic Partners’s iShares Biotechnology ETF IBB Stock Holding History

Corbenic Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$8K	Hold	78	–	–	0.01%	140
2017 Q3	$9K	Hold	78	–	–	0.01%	155
2017 Q2	$8K	Hold	78	–	–	0.01%	121
2017 Q1	$8K	Hold	78	–	–	0.01%	142
2016 Q4	$7K	Hold	78	–	–	0.01%	144
2016 Q3	$8K	Hold	78	–	–	0.01%	131
2016 Q2	$7K	Hold	78	–	–	0.01%	138
2016 Q1	$7K	Hold	78	–	–	0.01%	132
2015 Q4	$9K	Hold	78	–	–	0.01%	136
2015 Q3	$8K	Buy	+78	New	+$9.36K	0.01%	128

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Corbenic Partners's IBB Position: Q4 2017 in Review

Corbenic Partners held its iShares Biotechnology ETF (IBB) position steady in Q4 2017 at 78 shares worth $8K. The position accounts for 0.01% of the portfolio, ranked #140.

Corbenic Partners first reported a position in IBB in Q3 2015 and has held it in 10 quarters since. The position peaked at $9K in Q3 2017. 624 funds tracked by Wall St. Rank hold IBB as of Q4 2017.

Corbenic Partners held 78 shares of iShares Biotechnology ETF worth $8K as of Q4 2017.
Corbenic Partners left its iShares Biotechnology ETF share count unchanged in Q4 2017.
iShares Biotechnology ETF made up 0.01% of Corbenic Partners's portfolio in Q4 2017, its #140 holding.
Corbenic Partners first reported a position in iShares Biotechnology ETF in Q3 2015 and has held it in 10 quarters since.
Corbenic Partners's iShares Biotechnology ETF position peaked at $9K in Q3 2017.
624 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2017.

Based on Corbenic Partners's 13F filing for Q4 2017, filed 25 Jan 2018.